Compare WMS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMS | RDY |
|---|---|---|
| Founded | 1966 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 11.6B |
| IPO Year | 2014 | 2001 |
| Metric | WMS | RDY |
|---|---|---|
| Price | $147.14 | $13.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $181.25 | $16.90 |
| AVG Volume (30 Days) | 824.5K | ★ 2.2M |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | 0.48% | ★ 0.54% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.02 | N/A |
| Revenue | ★ $2,904,245,000.00 | N/A |
| Revenue This Year | $5.23 | $7.81 |
| Revenue Next Year | $12.79 | $3.20 |
| P/E Ratio | $29.74 | ★ $18.67 |
| Revenue Growth | ★ 1.04 | N/A |
| 52 Week Low | $100.60 | $12.82 |
| 52 Week High | $179.32 | $16.17 |
| Indicator | WMS | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 42.67 |
| Support Level | $143.91 | $13.32 |
| Resistance Level | $154.10 | $14.14 |
| Average True Range (ATR) | 4.97 | 0.23 |
| MACD | 2.41 | -0.04 |
| Stochastic Oscillator | 76.06 | 43.86 |
Advanced Drainage Systems Inc is the manufacturer of water management solutions in the stormwater and onsite septic wastewater industries, providing superior drainage solutions for use in the construction and agriculture marketplaces. Its products are used across a broad range of end markets and applications, including residential, non-residential, infrastructure and agriculture applications. It operates business in three distinct reportable segments: Pipe; International, and Infiltrator. It generates a greater proportion of revenue from its Pipe segment, which consists of Pipe product sales in the United States. The Infiltrator is a provider of plastic leachfield chambers and systems, septic tanks and accessories, for use in residential applications.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.